4 hours ago
Results of a phase 2 trial show Stelara (ustekinumab) significantly reduces disease activity in #lupus patients.lupusnewstoday.com/2017/11/07/systemic-lupus-erythematosus-activity-significantly-reduced-stelara... ... See MoreSee Less
Please click on the link below to visit our Eclipse Light Sensitivity Support Group.
Here you will find practical advice and information on managing light sensitivity.
GO TO ECLIPSE
St James House
Essex RM1 3NH
United Kingdom(00 44) (0)1708 731251Email Us